ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Zivo Bioscience, Inc.
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026
- Market cap
- $25.96M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2024
–
Consecutive increases
0 years
Not raised last year
Five-year growth
–
Per year, per share
Payout ratio, FY2024
–
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2024 | – | – | – | – |
| FY2023 | $3.11 | – | – | – |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.